Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
ID: 345025Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2M

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/345025

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-063.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2)," aimed at enhancing the capabilities of existing COBRE Phase 1 centers over a five-year period. Eligible applicants must hold an active COBRE Phase 1 award and demonstrate how previous funding has contributed to research success and institutional improvements, with a structured application that includes an Administrative Core, 2-5 Research Projects, and optional Research Cores. This initiative is crucial for fostering sustainable biomedical research centers at Institutional Development Award (IDeA)-eligible institutions, promoting diversity and collaboration among research teams. The program has an annual budget ceiling of $1.5 million, with applications due by May 28, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-063.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-063-Full-Announcement.html
    PAR-23-063.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is offering a funding opportunity titled "Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2)." This program aims to strengthen existing COBRE Phase 1 centers over a five-year period by enhancing research capacity and the ability of investigators to secure independent funding. Eligible applicants must have an active COBRE Phase 1 award and demonstrate how prior support has facilitated research success and improvements in institutional infrastructure. The COBRE Phase 2 program requires a structured application that includes an Administrative Core, 2-5 Research Projects, and optional Research Cores. Emphasis is placed on increasing user engagement with Research Cores and enhancing diversity through collaborative efforts. The application process mandates adherence to specific instructions for submission, highlighting the importance of compliance with funded project regulations. Key review criteria will focus on the significance of the research, accomplishments of the Phase 1 center, qualifications of leadership, innovation in proposed research, and the establishment of diverse research teams. With a budget limit of $1.5 million annually, the initiative seeks to foster successful biomedical research centers in IDeA-eligible institutions while promoting sustainability and capacity building in scientific research.
    Similar Opportunities
    Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)." This grant aims to support the transition of core resources and biomedical research activities at IDeA-eligible organizations into sustainable and independent operations following COBRE Phase 2 funding. The initiative is particularly significant for enhancing research capabilities and fostering inclusivity within research teams, as it requires a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Grants can provide up to $750,000 in annual direct costs over a five-year project period, with applications due by September 30, 2025. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-216.html.
    Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20) grants, aimed at enhancing biomedical research capacity at eligible institutions. The initiative seeks to establish thematic, multi-disciplinary centers that strengthen research infrastructure and support the development of investigators capable of competing for independent NIH research grants. This program is particularly significant for institutions in states with historically low success rates for NIH funding, as it aims to foster health-related research and improve competitiveness. Interested applicants can submit one application for funding, with a budget of up to $1.5 million annually for a maximum project period of five years, and must adhere to specific guidelines. The application deadline is January 30, 2025, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Institutional Development Award (IDeA) Networks of Biomedical Research Excellence (INBRE) program, aimed at enhancing the biomedical research capacity in IDeA-eligible states. This grant opportunity supports statewide networks of higher education and research institutions to foster faculty research, mentoring, and student involvement, with a focus on developing institutional infrastructure. The program allows for a maximum annual budget of $2.75 million over five years, requiring each application to include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research. Interested applicants can find more information and submit proposals by the closing date of May 22, 2025, and should direct inquiries to grantsinfo@nih.gov.
    Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for revision applications from currently funded Centers for AIDS Research (CFAR) and Developmental CFARs (D-CFAR) to enhance their support for outreach and research related to HIV and health disparities. The initiative aims to diversify and support the next generation of HIV/AIDS investigators by requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP), which will be a critical component of the application review process. This funding is vital for fostering innovative research and training programs that address key barriers in HIV research, particularly for underrepresented groups. The maximum award amount is $1.5 million annually, with applications due by October 9, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-080.html.
    Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Centers of Excellence in Genomic Science (CEGS) program, aimed at supporting innovative, interdisciplinary research in genomic science. This program seeks to establish academic centers that will develop transformative genomic approaches to address significant biomedical challenges, with a focus on integrating advanced technological and computational methods. Each award can provide up to $1.5 million per year for a maximum of five years, with potential renewal for an additional five years, and applications are due by June 23, 2025. Eligible applicants include a range of institutions such as higher education entities, nonprofits, and various government organizations, while foreign entities are not eligible. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Biomedical Research Facilities (C06 Clinical Trial Not Allowed) grant, aimed at funding the construction or modernization of biomedical research facilities. This initiative seeks to enhance research infrastructure in academic and nonprofit institutions, particularly focusing on Institutions of Emerging Excellence (IEEs), with an emphasis on projects that support core facilities for broad biomedical research collaboration. Eligible applicants can request up to $8 million over five years, with a strong interest in projects that address women's health, emerging research methods, and increasing breeding capacity for specific nonhuman primates. Interested parties should submit their applications by January 27, 2025, and can find more information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for competing revisions to existing Single Project Research Grants and Cooperative Agreements, with the option for clinical trials. This initiative allows NIH award recipients to apply for additional funds to expand their current projects within the relevant Institutes and Centers, specifically in response to Notices of Special Interest (NOSI) issued by participating NIH entities. The funding opportunity, identified as PA-23-317, is open to a wide range of eligible applicants, including higher education institutions, nonprofit organizations, and foreign entities, reflecting NIH's commitment to advancing impactful health research. Applications must be submitted by November 24, 2026, through the NIH ASSIST system or Grants.gov, and will be evaluated based on scientific merit and adherence to specified criteria. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) to enhance research on substance use, addiction, and HIV through collaborative efforts among investigators. This program aims to integrate diverse new and early career researchers, particularly from underrepresented backgrounds, to develop innovative approaches and interdisciplinary projects that transform the scientific research landscape. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, and government entities, with a maximum project period of five years and a requirement to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested parties should note that the application deadline is November 17, 2025, and can find more information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Polycystic Kidney Disease Core Centers (U54 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Polycystic Kidney Disease (PKD) Core Centers through a Notice of Funding Opportunity (NOFO) aimed at enhancing national research efforts in PKD. The initiative seeks to establish four Core Centers that will collaborate within the PKD Research Resource Consortium, focusing on developing and sharing essential research tools and resources while promoting scientific diversity and engagement among a wide range of investigators. Approximately $3.44 million in funding is anticipated for FY 2025, with applications due by November 15, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.